ADMA BIOLOGICS, INC. Share Repurchase Program Excise Tax
ADMA BIOLOGICS, INC. (ADMA) reported Share Repurchase Program Excise Tax of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity
us-gaap:ShareRepurchaseProgramExciseTax · last filed 2026-08-05
- ADMA BIOLOGICS, INC. share repurchase program excise tax for the quarter ending 2026-06-30 was $400.00K.
- ADMA BIOLOGICS, INC. share repurchase program excise tax for the quarter ending 2026-03-31 was $700.00K.
| Period end | Share Repurchase Program Excise Tax 3 month | Share Repurchase Program Excise Tax 6 month |
|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-05 | $1.10M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $700.00K 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |